BEIGELMAN LEONID innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	WIPO (World Intellectual Property Organization)	35
#2	United States	14

#	Technology
#1	Microorganisms
#2	Medical preparations
#3	Therapeutic chemical compounds
#4	Sugars
#5	Enzymes
#6	Climate change adaptation technologies
#7	Heterocyclic compounds
#8	Special acyclic compounds
#9	Acyclic or carbocyclic compounds

Publication	Filing date	Title
US2012070411A1	2011-09-19	Substituted nucleotide analogs
US2011313024A1	2011-07-25	RNA INTERFERENCE MEDIATED INHIBITION OF PROPROTEIN CONVERTASE SUBTILISIN KEXIN 9 (PCSK9) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
US2012041184A1	2011-07-11	RNA INTERFERENCE MEDIATED INHIBITION OF HUMAN IMMUNODEFICIENCY VIRUS (HIV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO2004097020A2	2004-04-23	Rna interference mediated inhibition of map kinase gene expression
WO03070918A2	2003-02-20	Rna interference by modified short interfering nucleic acid
WO03070912A2	2003-02-20	RNA INTERFERENCE MEDIATED INHIBITION OF EPIDERMAL GROWTH FACTOR RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO03070910A2	2003-02-20	INHIBITION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) AND VEGF RECEPTOR GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO03070895A2	2003-02-18	RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO03070966A2	2003-02-14	RNA INTERFERENCE MEDIATED TARGET DISCOVERY AND TARGET VALIDATION USING SHORT INTERFERING NUCLEIC ACID (siNA)
WO0159102A2	2001-02-08	Nucleozymes with endonuclease activity